ARCH VENTURE MANAGEMENT, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | VIR | 12.92M | $73.75M |
 | ERAS | 11.06M | $24.10M |
 | GOSS | 8.06M | $21.19M |
 | BEAM | 4.54M | $110.19M |
 | MAZE | 4.12M | $106.83M |
 | RAPP | 3.73M | $110.74M |
 | LYEL | 2.76M | $44.81M |
 | QTTB | 320K | $634.55K |
Vir Biotechnology, Inc.
VIR
Shares Held
12.92M
Value
$73.75M
Erasca, Inc.
ERAS
Shares Held
11.06M
Value
$24.10M
Gossamer Bio, Inc.
GOSS
Shares Held
8.06M
Value
$21.19M
Beam Therapeutics Inc.
BEAM
Shares Held
4.54M
Value
$110.19M
Maze Therapeutics, Inc.
MAZE
Shares Held
4.12M
Value
$106.83M
Rapport Therapeutics, Inc. Common Stock
RAPP
Shares Held
3.73M
Value
$110.74M
Lyell Immunopharma, Inc.
LYEL
Shares Held
2.76M
Value
$44.81M
Q32 Bio Inc.
QTTB
Shares Held
320K
Value
$634.55K